2017 年 2 月美国、欧盟和日本新批准药物概述
An Overview of New Drugs Approved in the US, EUand Japan in February 2017
中文关键词  
DOI:
中文关键词:  新药批准  临床试验  新分子实体  新生物制品
英文关键词:drug approval  clinical trial  new molecular entity  new biologics
基金项目:
作者单位
孙友松  
摘要点击次数: 588
全文下载次数: 530
中文摘要:
      2017 年 2 月,美国、欧盟和日本共批准 16 个新药,包括新分子实体、新有效成分、新生物制品、新增适应证及新剂型药物。 对全球首次获得批准的新分子实体、新有效成分、新生物制品进行分析,重点介绍这些药物的临床研究结果和研发历史进程。
英文摘要:
      In February 2017, US Food and Drug Administration (FDA), European Commission, and Japanese Ministry of Health, Labour and Welfare (MHLW ) had totally approved 16 new drugs, including new molecular entities, new active ingredients, new biologics and new line extensions (new indications and new formulations). In this article, new molecular entities, new active ingredients and new biologics receiving their rst global approval were analyzed with emphasis on the outcomes of clinical trials and development histories.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器
关闭